ACT-W SRL
ACT-W reported total assets of 27,136 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Mar 2026).
The score of ACT-W shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ACT-W's annual accounts
| 2025 | |
|---|---|
| Net result | −2,864 € |
| Equity | 27,136 € |
| Cash | 25,851 € |
| EBITDA | −1,444 € |
| Total assets | 27,136 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Mar 2026
ACT-W's financial analysis
- Solvency100.0%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ACT-W
ACT-W's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1024.207.855
- VAT number
- BE1024207855
- Peppol
- Registered · 0208:1024207855 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 11 Jun 2025
- Registered office
- 4550 Nandrin
- Latest accounts
- 2025 · filed on 02 Mar 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 72109)
ACT-W (SRL) has been based in Nandrin since 2025, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 2,864 € and equity of 27,136 €; its revenue is not published. Its solvency stands at 100.0%, above the median of its sector (58.2%).
Companies similar to ACT-W
Companies in the same business, of comparable size and area, outside its group.
- Alanine Research and experimental development on natural sciences and engineering Lasne · balance sheet 28,321 €
- IQVIA Cancer Research Research and experimental development on natural sciences and engineering Zaventem · balance sheet €1.07m
- Bimsconsult Research and experimental development on natural sciences and engineering Auderghem · balance sheet 463,296 €
- Microbio Research and experimental development on natural sciences and engineering Berlaar · balance sheet 24,493 €
- OPO Research and experimental development on natural sciences and engineering Thimister-Clermont · balance sheet 22,711 €
- GrO2 Research and experimental development on natural sciences and engineering Mol · balance sheet 22,362 €
- Jacobs Consultancy Research and experimental development on natural sciences and engineering Antwerp · balance sheet 16,077 €
- Evalchemist Research and experimental development on natural sciences and engineering Lasne · balance sheet 15,464 €
Frequently asked questions about ACT-W
What is the revenue of ACT-W?
ACT-W files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ACT-W?
In Belgium, the VAT number is the company number prefixed with BE: BE1024207855 for ACT-W, if the company is VAT-registered. Its company number (CBE) is 1024.207.855.
Where is the registered office of ACT-W?
According to the CBE register, the registered office of ACT-W is in 4550 Nandrin.
What is the equity of ACT-W?
At the close of the 2025 financial year, the equity of ACT-W amounts to 27,136 €, a solvency of 100.0% of total assets.
Who manages ACT-W?
The register lists 2 active mandates at ACT-W. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ACT-W
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →